产地 | 进口、国产 |
品牌 | 上海莼试 |
保存条件 | Store at -20 °C |
货号 | CS11155 |
应用范围 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS编号 | |
抗体名 | Anti-RAR alpha |
克隆性 | |
靶点 | 详见说明书 |
适应物种 | 详见说明书 |
形态 | 详见说明书 |
宿主 | 详见说明书 |
亚型 | IgG |
标识物 | 详见说明书 |
浓度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human Retinoic acid Receptor Alpha |
中文名称 维甲酸受体RAR α/RAR α抗体品牌
英文名称 Anti-RAR alpha
别 名 Acute Promelocytic Leukemia Breakpoint Cluster Region; Acute Promelocytic Leukemia Breakpoint Cluster Region; NR1B1; Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein; Nuclear receptor subfamily 1 group B member 1; Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form; RAR A; RAR alpha; RAR alpha; RAR alpha form; RAR alpha form; RAR; RAR-alpha; RARA; RARA; RARA protein; RARA/PML Fusion Gene; RARA/PML Fusion Gene; RARA_HUMAN; RARalpha; RARalpha1; Retinoic acid receptor alpha; Retinoic acid receptor alpha polypeptide
产品属性:
维甲酸受体RAR α/RAR α抗体品牌 浓 度 1mg/1ml
规 格 0.1ml/100μg 0.2ml/200μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat
产品类型 一抗
研究领域 细胞生物 免疫学 神经生物学 信号转导 细胞凋亡 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 48kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Retinoic acid Receptor Alpha
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
维甲酸受体RAR α/RAR α抗体品牌 产品应用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Retinoic acid receptor alpha (RAR-alpha) is a receptor for retinoic acid. This metabolite has profound effects on vertebrate development. Retinoic acid is a morphogen and is a powerful teratogen. This receptor controls cell function by directly regulating gene expression. Subunit: Interacts with CDK7 (By similarity). Interacts with NCOA3 and NCOA6 coactivators, leading to a strong increase of transcription of target genes.
Function : Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis. Has a role in the survival of early spermatocytes at the beginning prophase of meiosis. In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes. In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Regulates expression of target genes in a ligand-dependent manner by recruiting chromatin complexes containing MLL5. Mediates retinoic acid-induced granulopoiesis.
Subunit : Heterodimer; with RXRA. Binds DNA preferentially as a heterodimer. Interacts with CDK7 By similarity. Interacts with coactivators NCOA3 and NCOA6. Interacts with NCOA7; the interaction requires ligand-binding. Interacts with MLL5. Interacts (via the ligand-binding domain) with PRAME; the interaction is ligand (retinoic acid)-dependent. Interacts with AKT1; the interaction phosphorylates RARA and represses transactivation. Interacts with PRKAR1A; the interaction negatively regulates RARA transcriptional activity. Interacts with NCOR1 and NCOR2. Interacts with PRMT2. Interacts with LRIF1. Interacts with ASXL1 and NCOA1.
Subcellular Location : Nucleus. Cytoplasm. Nuclear localization depends on ligand binding, phosphorylation and sumoylation. Transloaction to the nucleus in the absence of ligand is dependent on activation of PKC and the downstream MAPK phosphorylation.
Post-translational modifications : Phosphorylated on serine and threonine residues. Phosphorylation does not change during cell cycle. Phosphorylation on Ser-77 is crucial for transcriptional activity. Phosphorylation by AKT1 is required for the repressor activity but has no effect on DNA binding, protein stability nor subcellular localization. Phosphorylated by PKA in vitro. This phosphorylation on Ser-219 and Ser-369 is critical for ligand binding, nuclear localization and transcriptional activity in response to FSH signaling.
Sumoylated with SUMO2, mainly on Lys-399 which is also required for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a confromational change may occur that allows sumoylation on two additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6. Sumoylation levels determine nuclear localization and regulate ATRA-mediated transcriptional activity.
Trimethylation enhances heterodimerization with RXRA and positively modulates the transcriptional activation.
Ubiquitinated.
DISEASE : Chromosomal aberrations involving RARA are commonly found in acute promyelocytic leukemia. Translocation t(11;17)(q32;q21) with ZBTB16/PLZF; translocation t(15;17)(q21;q21) with PML; translocation t(5;17)(q32;q11) with NPM. The PML-RARA oncoprotein requires both the PML ring structure and coiled-coil domain for both interaction with UBE2I, nuclear microspeckle location and sumoylation. In addition, the coiled-coil domain functions in blocking RA-mediated transactivation and cell differentiation.
Similarity : Belongs to the nuclear hormone receptor family. NR1 subfamily.
Contains 1 nuclear receptor DNA-binding domain.
Database links : Entrez Gene: 5914 Human
Entrez Gene: 19401 Mouse
Entrez Gene: 24705 Rat
Omim: 180240 Human
SwissProt: P10276 Human
SwissProt: P11416 Mouse
Unigene: 654583 Human
Unigene: 439744 Mouse
类固醇受体(Steroid Receptors) RAR-α在人组织细胞分化过程中具有重要作用,尤其在分化的特殊阶段起到一定的作用,在造血细胞中,RARα表达丰富。
实验流程:
全、新、优、品、好四大特点:
维甲酸受体RAR α/RAR α抗体品牌 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。
新:产品更新速度较快,基本上每周都有新产品出现。
优:产品质量好,投诉比较少。
好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
技术外包服务:
★维甲酸受体RAR α/RAR α抗体品牌 分子生物学:质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等
★蛋白工程:原核、哺乳动物蛋白表达系统等
★病毒包装:腺病毒、慢病毒等
★抗体工程:磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
正在热销的相关产品:
IL-14/Taxilin alpha 白介素14抗原Multi-class antibodies规格: 0.5mg
Anti-Ack1 醋酸激酶1抗体Multi-class antibodies规格: 0.2ml
Rhesus antibody Rh phospho-CDKN1A/P21 (Thr57) 磷酸化p21蛋白抗体 规格 0.1ml
鸡IgG 干粉 10mg/50mg 国产
Wilms Tumor Protein 英文名称: 肾母细胞瘤蛋白抗体 0.1ml
DPP2 英文名称: 溶酶体丝酸蛋白酶DPP2抗体 0.1ml
Anti-Ack1 醋酸激酶1抗体Multi-class antibodies规格: 0.2ml
Anti-PACAP-38 /FITC 荧光素标记腺苷酸环化酶激活肽-38抗体IgGMulti-class antibodies规格: 0.2ml
Rabbit Anti-rat IgG/Biotin 生物素化兔抗大鼠IgGMulti-class antibodies规格: 0.1ml
周期素B1抗体 Anti-Cyclin B1 0.1ml
Rabbit anti-MG IgG/PE-Cy5.5 PE-Cy5.5标记的兔抗长爪沙鼠IgG 0.1ml
FLCN 英文名称: 卵巢滤泡激素抗体(BHD综合征) 0.1ml
Rhesus antibody Rh phospho-VEGF receptor 2 (Tyr1059) 磷酸化内皮生长因子受体2抗体 规格 0.1ml
Rabbit Anti-rat IgG/Biotin 生物素化兔抗大鼠IgGMulti-class antibodies规格: 0.1ml
Streptococcus suis 2 英文名称: 2型猪链球菌菌体蛋白抗体 0.2ml
Eph receptor A5 英文名称: 酪酸蛋白激酶A5受体抗体 0.1ml
抗磷酸化原癌基因c-kit抗体 Anti-phospho-c-kit/SCFR/CD117 0.1ml
Anti-VCP/p97 /FITC 荧光素标记抗含缬酪肽蛋白抗体IgGMulti-class antibodies规格: 0.2ml
Rhesus antibody Rh phospho-HDAC6 (Ser22) 磷酸化组蛋白去乙酰化酶6抗体 规格 0.1ml
CD44 CD44抗原 (多肽抗原)Multi-class antibodies规格: 0.5mg
人平滑肌细胞
Panc10.05 *腺癌
LTF Others Human 人 LTF / Lactoferrin / Lactoansferrin 人细胞裂解液 (阳性对照)
CL-0450SW 982(人滑膜细胞)5×106cells/瓶×2
人肾近曲小管上皮细胞RNAHRPTEpiC miRNA5 μg
人二倍体细胞;HEL 人小肠平滑肌细胞完全培养基 100mL
CL-0199RSC96(大鼠雪旺细胞)5×106cells/瓶×2
ALPI Others Human 人 Alkaline Phosphatase / ALPI 人细胞裂解液 (阳性对照)
小鼠食管平滑肌细胞完全培养基 100mL
MDCK[NBL-2]狗肾上皮细胞 MDCK[NBL-2] canine kidney epithelial cells MEM+10% FBS
白细胞介素-6超家族
R 1610(仓鼠肺细胞) 5×106cells/瓶×2 HL-60(原髓细胞)
维甲酸受体RAR α/RAR α抗体品牌 人平滑肌细胞
Panc10.05 *腺癌
LTF Others Human 人 LTF / Lactoferrin / Lactoansferrin 人细胞裂解液 (阳性对照)
CL-0450SW 982(人滑膜细胞)5×106cells/瓶×2
人肾近曲小管上皮细胞RNAHRPTEpiC miRNA5 μg
人二倍体细胞;HEL 人小肠平滑肌细胞完全培养基 100mL